SG Americas Securities’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-38,231
Closed -$102K 3780
2017
Q1
$102K Buy
+38,231
New +$96.8K ﹤0.01% 2983
2016
Q2
Sell
-3,309
Closed -$53K 3305
2016
Q1
$53K Buy
+3,309
New +$45.2K ﹤0.01% 2756
2014
Q4
Sell
-2,838
Closed -$43K 3567
2014
Q3
$43K Buy
+2,838
New +$56.1K ﹤0.01% 2506
2014
Q2
Sell
-11,522
Closed -$241K 2915
2014
Q1
$241K Buy
+11,522
New +$409K ﹤0.01% 1858

Other funds holding CYTR

SG Americas Securities's CYTR Position: Q2 2017 in Review

SG Americas Securities sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 38,231 shares — an estimated $102K sold.

SG Americas Securities first reported a position in CYTR in Q1 2014 and held it in 4 quarters. The position peaked at $241K in Q1 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

  • SG Americas Securities reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
  • SG Americas Securities sold 38,231 CytRx Corp shares in Q2 2017, an estimated $102K.
  • SG Americas Securities first reported a position in CytRx Corp in Q1 2014 and held it in 4 quarters.
  • SG Americas Securities's CytRx Corp position peaked at $241K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on SG Americas Securities's 13F filing for Q2 2017, filed 3 Aug 2017.